Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

BACKGROUND: The combination of tyrosine kinase inhibitors (TKIs) and anti-PD-1 antibodies with hepatic arterial infusion chemotherapy (HAIC) or transarterial chemoembolization (TACE) has shown encouraging anti-tumor effects in the treatment of hepatocellular carcinoma (HCC). We explored the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Bingran, Zhang, Ning, Feng, Yun, Zhang, Yongfa, Zhang, Ti, Wang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563810/
https://www.ncbi.nlm.nih.gov/pubmed/37822726
http://dx.doi.org/10.2147/JHC.S431917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563810/
https://www.ncbi.nlm.nih.gov/pubmed/37822726
http://dx.doi.org/10.2147/JHC.S431917

Ejemplares similares